en

PRODUCT DETAIL

Dexamethasone phosphate Krka 8 mg/2 ml injekčný/infúzny roztok

Code 3605D
MA number 56/0029/20-S
Product Form: sol ijf 5x2 ml (amp.skl.jantárová)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 56 - HORMONA (LIEČIVA S HORMONÁLNOU AKTIVITOU)
ATC:
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H02 CORTICOSTEROIDS FOR SYSTEMIC USE
H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
H02AB Glucocorticoids
H02AB02 Dexamethasone
Shelf life: 24
Container: amber glass ampoule
Route of admin.: Intramuscular or intravenous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 14.02.2020
Validity: 14.02.2025
MA renewed: Renewal application submitted
Pediatric posology: Yes
Pediatric warnings: Yes
SPC: SPC_Dexamethasone phosphate Krka sol ijf_06_2022.pdf  
PIL: PIL_Dexamethasone phosphate Krka_sol ijf_06_2022.pdf  
Safety feature Yes
Data update: 28.02.2020
eu-flag.png sk-flag.png